These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 37739513)

  • 1. Chitosan-based nano-micelles for potential anti-tumor immunotherapy: Synergistic effect of cGAS-STING signaling pathway activation and tumor antigen absorption.
    Zhang S; Zeng Y; Wang K; Song G; Yu Y; Meng T; Yuan H; Hu F
    Carbohydr Polym; 2023 Dec; 321():121346. PubMed ID: 37739513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC.
    Li K; Gong Y; Qiu D; Tang H; Zhang J; Yuan Z; Huang Y; Qin Y; Ye L; Yang Y
    J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36002188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A General Biomineralization Strategy to Synthesize Autologous Cancer Vaccines with cGAS-STING Activating Capacity for Postsurgical Immunotherapy.
    Li Q; Dong Z; Cao Z; Lei H; Wang C; Hao Y; Feng L; Liu Z
    ACS Nano; 2023 Jun; 17(11):10496-10510. PubMed ID: 37184402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies.
    Zhang J; Yu S; Peng Q; Wang P; Fang L
    Cancer Biol Med; 2024 Jan; 21(1):45-64. PubMed ID: 38172538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific activation of cGAS-STING pathway by nanotherapeutics-mediated ferroptosis evoked endogenous signaling for boosting systemic tumor immunotherapy.
    Liang JL; Jin XK; Zhang SM; Huang QX; Ji P; Deng XC; Cheng SX; Chen WH; Zhang XZ
    Sci Bull (Beijing); 2023 Mar; 68(6):622-636. PubMed ID: 36914548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomaterial-mediated modulation of the cGAS-STING signaling pathway for enhanced cancer immunotherapy.
    Wang Y; Liu Y; Zhang J; Peng Q; Wang X; Xiao X; Shi K
    Acta Biomater; 2024 Mar; 176():51-76. PubMed ID: 38237711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrinsic strategies for the evasion of cGAS-STING signaling-mediated immune surveillance in human cancer: How therapy can overcome them.
    Zou SS; Qiao Y; Zhu S; Gao B; Yang N; Liu YJ; Chen J
    Pharmacol Res; 2021 Apr; 166():105514. PubMed ID: 33631336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metal coordination nanotheranostics mediated by nucleoside metabolic inhibitors potentiate STING pathway activation for cancer metalloimmunotherapy.
    Yang L; Wang Y; Song Y; Li Z; Lei L; Li H; He B; Cao J; Gao H
    J Control Release; 2024 Jun; 370():354-366. PubMed ID: 38685387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ectopic expression of cGAS in
    Waanders L; van der Donk LEH; Ates LS; Maaskant J; van Hamme JL; Eldering E; van Bruggen JAC; Rietveld JM; Bitter W; Geijtenbeek TBH; Kuijl CP
    J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37072345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy.
    Lv M; Chen M; Zhang R; Zhang W; Wang C; Zhang Y; Wei X; Guan Y; Liu J; Feng K; Jing M; Wang X; Liu YC; Mei Q; Han W; Jiang Z
    Cell Res; 2020 Nov; 30(11):966-979. PubMed ID: 32839553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cGAS-STING Pathway as the Target of Immunotherapy for Lung Cancer.
    Dan Q; Yang Y; Ge H
    Curr Cancer Drug Targets; 2023; 23(5):354-362. PubMed ID: 36380440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remodeling of Tumor Microenvironment by Nanozyme Combined cGAS-STING Signaling Pathway Agonist for Enhancing Cancer Immunotherapy.
    Dong W; Chen M; Chang C; Jiang T; Su L; Chen C; Zhang G
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cGAS-STING pathway mediates activation of dendritic cell sensing of immunogenic tumors.
    Li G; Zhao X; Zheng Z; Zhang H; Wu Y; Shen Y; Chen Q
    Cell Mol Life Sci; 2024 Mar; 81(1):149. PubMed ID: 38512518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mn-based cGAS-STING activation for tumor therapy.
    Huang A; Zhou W
    Chin J Cancer Res; 2023 Feb; 35(1):19-43. PubMed ID: 36910853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy.
    Zheng J; Mo J; Zhu T; Zhuo W; Yi Y; Hu S; Yin J; Zhang W; Zhou H; Liu Z
    Mol Cancer; 2020 Aug; 19(1):133. PubMed ID: 32854711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies involving STING pathway activation for cancer immunotherapy: Mechanism and agonists.
    Pan X; Zhang W; Guo H; Wang L; Wu H; Ding L; Yang B
    Biochem Pharmacol; 2023 Jul; 213():115596. PubMed ID: 37201875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing anti-tumor immunity through liposomal oxaliplatin and localized immunotherapy via STING activation.
    Gu Z; Hao Y; Schomann T; Ossendorp F; Ten Dijke P; Cruz LJ
    J Control Release; 2023 May; 357():531-544. PubMed ID: 37030544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manganese Coordination Micelles That Activate Stimulator of Interferon Genes and Capture In Situ Tumor Antigens for Cancer Metalloimmunotherapy.
    Li J; Ren H; Qiu Q; Yang X; Zhang J; Zhang C; Sun B; Lovell JF; Zhang Y
    ACS Nano; 2022 Oct; 16(10):16909-16923. PubMed ID: 36200692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cGAS/STING Pathway: A Novel Target for Cancer Therapy.
    Gan Y; Li X; Han S; Liang Q; Ma X; Rong P; Wang W; Li W
    Front Immunol; 2021; 12():795401. PubMed ID: 35046953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cGAS-STING signaling in cancer immunity and immunotherapy.
    Du H; Xu T; Cui M
    Biomed Pharmacother; 2021 Jan; 133():110972. PubMed ID: 33254021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.